Unveiling the Silent Intruder: H. pylori's Hidden Link to Ischemic Heart Disease

Kanishk Aggarwal1, Sandeep Singh2, Ankur Singla1

  • 1From the Department of Internal Medicine, Dayanand Medical College and Hospital, Ludhiana, Punjab, India.

Cardiology in Review
|March 6, 2024
PubMed

Insights

Helicobacter pylori infection is linked to cardiovascular disease through chronic inflammation and altered risk factors. This review explores cardiac issues and mechanisms related to H. pylori.

Area of Science:

  • Cardiology
  • Infectious Diseases
  • Gastroenterology

Background:

  • Cardiovascular disease (CVD) is a leading cause of mortality globally.
  • Established CVD risk factors include age, diabetes mellitus, smoking, hypertension, and obesity.
  • Emerging evidence suggests a link between Helicobacter pylori (H. pylori) infection and cardiac complications.

Purpose of the Study:

  • To review the cardiac manifestations associated with H. pylori infection.
  • To elucidate the pathophysiological mechanisms underlying the relationship between H. pylori and cardiovascular disease.

Main Methods:

  • Literature review of studies investigating H. pylori and cardiac conditions.
  • Analysis of virulent factors of H. pylori implicated in coronary artery disease.
  • Examination of proposed pathogenic mechanisms linking H. pylori to CVD.

Main Results:

  • H. pylori, primarily known for gastric issues, is increasingly recognized for extra-gastric manifestations, including cardiac problems.
  • Virulent factors such as vacuolating cytotoxin gene A (vacA) and cytotoxin-associated gene A (cagA) are key in H. pylori-related coronary artery disease.
  • The infection likely initiates chronic inflammation, modifies traditional risk factors, and promotes prothrombotic states.

Conclusions:

  • H. pylori infection may contribute to cardiovascular disease development and progression.
  • Understanding the link between H. pylori and cardiac issues is crucial for comprehensive patient management.
  • Further research is warranted to fully clarify the role of H. pylori in cardiovascular pathology.

Related Concept Videos

Peptic Ulcer Disease I: Introduction01:30

Peptic Ulcer Disease I: Introduction

Peptic Ulcer Disease (PUD) is characterized by mucosal excavation in the esophagus, stomach, pylorus, or duodenum. It can manifest as acute or chronic based on the extent and duration of mucosal involvement.
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
168
Pathophysiology of Peptic Ulcer Disease: Injurious Factors01:22

Pathophysiology of Peptic Ulcer Disease: Injurious Factors

Peptic ulcers are sores on the stomach's inner lining and the upper small intestine, which are the result of disruptions in the mucosal layer that houses parietal cells which produce gastric acid, and chief cells which secrete pepsinogen.
In the antrum region, G cells secrete the gastrin hormone that binds to gastrin-cholecystokinin-B (CCK2) receptors on parietal and enterochromaffin-like (ECL) cells in the fundic glands. Simultaneously, the vagus nerve releases acetylcholine, which binds...
591
Ischemic Heart Disease: Overview01:17

Ischemic Heart Disease: Overview

Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
1.3K
Gastritis-II: Pathophysiology01:17

Gastritis-II: Pathophysiology

Gastritis is marked by disruption of the mucosal barrier that usually protects the stomach tissue from digestive juices and manifests in acute and chronic forms.
In acute gastritis, the gastric mucosa becomes swollen and red and undergoes superficial erosion. Superficial ulceration may lead to bleeding.
In chronic gastritis, persistent or repeated insults lead to chronic inflammatory changes and, eventually, thinning or atrophy of the gastric tissue.
Gastritis can stem from various causes, each...
326
Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy01:16

Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy

Helicobacter pylori, a resilient gram-negative bacterium, can thrive in the stomach's harsh, acidic environment. Infection with H. pylori leads to a cascade of events within the stomach lining. One of the critical disruptions caused by this bacterium is the interference with somatostatin production, a hormone responsible for regulating acid secretion. This interference tips the balance, escalating acid secretion and diminishing bicarbonate levels. This imbalance compromises the defensive...
397
Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies01:28

Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies

Peptic ulcer disease (PUD) presents with diverse symptoms depending on the location and severity of the ulcer. Clinical manifestations of peptic ulcer include dull pain and a burning sensation in the mid-epigastric region.
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
117